Business Description

Description
Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -3.98
Debt-to-Equity -2.36
Debt-to-EBITDA -14.63
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -615.04
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EPS without NRI Growth Rate 20.6
3-Year FCF Growth Rate 20.6

Momentum Rank

Name Current Vs Industry Vs History
9-Day RSI 31.4
14-Day RSI 32.84
6-1 Month Momentum % -46.43
12-1 Month Momentum % -67.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.04
Quick Ratio 0.04
Cash Ratio 0.01
Days Sales Outstanding 106.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.8
Shareholder Yield % 3.08

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -139.02
Net Margin % -151.22
FCF Margin % -101.22
ROA % -97.95
ROIC % -14.23
ROC (Joel Greenblatt) % -178.57

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A
EV-to-EBIT -10.88
EV-to-EBITDA -20.04
EV-to-Revenue 13.93
EV-to-FCF -13.76
Earnings Yield (Greenblatt) % -9.19
FCF Yield % -26.35

Financials

SGBI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:SGBI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sangui Biotech International Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.082
EPS (TTM) ($) 0
Beta 0.71
Volatility % 71.98
14-Day RSI 32.84
14-Day ATR ($) 0.000009
20-Day SMA ($) 0.0015
12-1 Month Momentum % -67.39
52-Week Range ($) 0.0012 - 0.02
Shares Outstanding (Mil) 209.9

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sangui Biotech International Inc Filings

Filing Date Document Date Form
No Filing Data

Sangui Biotech International Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Sangui Biotech International Inc Frequently Asked Questions

What is Sangui Biotech International Inc(SGBI)'s stock price today?
The current price of SGBI is $0.00. The 52 week high of SGBI is $0.02 and 52 week low is $0.00.
When is next earnings date of Sangui Biotech International Inc(SGBI)?
The next earnings date of Sangui Biotech International Inc(SGBI) is .
Does Sangui Biotech International Inc(SGBI) pay dividends? If so, how much?
Sangui Biotech International Inc(SGBI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1